Current and future treatment options for pemphigus: Is it time to move towards more effective treatments?Soheil Tavakolpour(Shahid Beheshti University)International ImmunopharmacologyOctober 29, 201710.1016/j.intimp.2017.10.027Cited by 91SaveCiteExport RISWatch citationsAbstractRelated PapersHow corticosteroids control inflammation: Quintiles Prize Lecture 2005Peter J. Barnes|British Journal of Pharmacology|2006|814Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapyBernice Lo, Kejian Zhang, Wei Lü et al.|Science|2015|680A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of PemphigusStefan Beissert, Thomas Werfel, Uta Frieling et al.|Archives of Dermatology|2006|256SOME OBSERVATIONS ON THE EFFECT OF FOLIC ACID ANTAGONISTS ON ACUTE LEUKEMIA AND OTHER FORMS OF INCURABLE CANCERSidney Farber|Blood|1949|212Rituximab‐Induced T Cell Depletion in Patients With Rheumatoid Arthritis: Association With Clinical ResponseJ Melet, Denis Mulleman, Philippe Goupille et al.|Arthritis & Rheumatism|2013|162